SecurityXS2231188876 / Vmed O2 UK Financing I PLC - 3.25% 2031-01-31
InstitutionBlackrock Multi-sector Opportunities Trust
Latest Disclosed Value $ 134,712
Blackrock Multi-sector Opportunities Trust ownership in XS2231188876 / Vmed O2 UK Financing I PLC

2024-02-26 - Blackrock Multi-sector Opportunities Trust has filed a NPORT-P form disclosing ownership of Vmed O2 UK Financing I PLC (GB:XS2231188876) valued at $134,712 USD as of 2023-12-31. Blackrock Multi-sector Opportunities Trust had filed a previous NPORT-P on 2023-11-28 disclosing shares of Vmed O2 UK Financing I PLC valued at of $114,985 USD. This represents a change in value of 17.54 percent during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2024-02-26 2023-12-31 NP Vmed O2 UK Financing I DBT XS2231188876 135 17.54 0.0814
2023-11-28 2023-09-30 NP Vmed O2 UK Financing I DBT XS2231188876 115 -4.20 0.0631
2023-08-25 2023-06-30 NP Vmed O2 UK Financing I DBT XS2231188876 119 1.71 0.0628
2023-05-26 2023-03-31 NP Vmed O2 UK Financing I DBT XS2231188876 117 4.46 0.0574
2023-02-27 2022-12-31 NP Vmed O2 UK Financing I DBT XS2231188876 113 14.29 0.0528
2022-11-25 2022-09-30 NP Vmed O2 UK Financing I DBT XS2231188876 98 -8.41 0.0446
2022-08-25 2022-06-30 NP Vmed O2 UK Financing I DBT XS2231188876 107 -20.74 0.0451
2022-05-26 2022-03-31 NP Vmed O2 UK Financing I DBT XS2231188876 135 -10.00 0.0484
2022-02-25 2021-12-31 NP Vmed O2 UK Financing I DBT XS2231188876 150 -5.06 0.0475
2021-11-24 2021-09-30 NP Vmed O2 UK Financing I DBT XS2231188876 158 0.00 0.0471
2021-08-26 2021-06-30 NP Vmed O2 UK Financing I DBT XS2231188876 158 1.28 0.0452
2021-05-27 2021-03-31 NP Vmed O2 UK Financing I DBT XS2231188876 157 -6.02 0.0445
2021-02-25 2020-12-31 NP Vmed O2 UK Financing I DBT XS2231188876 167 7.79 0.0464
2020-11-25 2020-09-30 NP Vmed O2 UK Financing I DBT XS2231188876 155 0.0456
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.